Warning: The NCBI web site requires JavaScript to function. more...
Sedentary subjects have higher PAI-1 and lipoproteins levels than highly trained athletes.
Lira FS, Rosa JC, Lima-Silva AE, Souza HA, Caperuto EC, Seelaender MC, Damaso AR, Oyama LM, Santos RV.
Diabetol Metab Syndr. 2010 Jan 22;2:7.
Related citations
Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C.
Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9.
Comparison of the lipid profile and lipoprotein(a) between sedentary and highly trained subjects.
Lippi G, Schena F, Salvagno GL, Montagnana M, Ballestrieri F, Guidi GC.
Clin Chem Lab Med. 2006;44(3):322-6.
Effects of high and low intensity aerobic conditioning programs on blood fibrinolysis and lipid profile.
el-Sayed MS.
Blood Coagul Fibrinolysis. 1996 Jun;7(4):484-90.
Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
Lepira FB, M'Buyamba-Kabangu JR, Kayembe KP, Nseka MN.
Cardiovasc J S Afr. 2005 Sep-Oct;16(5):249-55.
LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
Ambrosch A, Mühlen I, Kopf D, Augustin W, Dierkes J, König W, Luley C, Lehnert H.
Diabetes Care. 1998 Dec;21(12):2077-84.
Relationship of body composition and cardiovascular fitness to lipoprotein lipid profiles in master athletes and sedentary men.
Yataco AR, Busby-Whitehead J, Drinkwater DT, Katzel LI.
Aging (Milano). 1997 Feb-Apr;9(1-2):88-94.
High-sensitive C-reactive protein level and oxidative stress-related status in former athletes in relation to traditional cardiovascular risk factors.
Pihl E, Zilmer K, Kullisaar T, Kairane C, Pulges A, Zilmer M.
Atherosclerosis. 2003 Dec;171(2):321-6.
The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.
Orem A, Yandi YE, Vanizor B, Cimşit G, Uydu HA, Malkoç M.
Clin Biochem. 2002 May;35(3):217-24.
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ, Watson KE, Talbert RL.
J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.
Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Gürlek A, Bayraktar M, Kirazli S.
Diabetes Care. 2000 Jan;23(1):88-92.
Inflammatory cardiovascular risk markers in women with hypopituitarism.
Sesmilo G, Miller KK, Hayden D, Klibanski A.
J Clin Endocrinol Metab. 2001 Dec;86(12):5774-81.
Fibrinolytic response in subjects with hypertriglyceridemia and low HDL cholesterol.
Cimminiello C, Vigorelli P, Piliego T, Soncini M, Toschi V, Arpaia G, Perolini S, Bonfardeci C.
Biomed Pharmacother. 1997;51(4):164-9.
Serum lipid profile in pubescent athletes.
Taralov Z, Boyadjiev N, Georgieva K.
Acta Physiol Pharmacol Bulg. 2000;25(1):3-8.
Physical activity, hormone replacement therapy and plasma lipoprotein-lipid levels in postmenopausal women.
Hagberg JM, McCole SD, Ferrell RE, Zmuda JM, Rodgers KS, Wilund KR, Moore GE.
Int J Sports Med. 2003 Jan;24(1):22-9.
Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E, Giorgino R.
Metabolism. 1997 Nov;46(11):1287-93.
Hemostatic variables, carbohydrate metabolism and lipid profile in women with low body mass index.
Polac I, Stachowiak G, Jedrzejczyk S, Stetkiewics T, Sobieszczanska S, Pertynski T.
Gynecol Endocrinol. 2003 Apr;17(2):151-7.
LDL from aerobically-trained subjects shows higher resistance to oxidative modification than LDL from sedentary subjects.
Sánchez-Quesada JL, Ortega H, Payés-Romero A, Serrat-Serrat J, González-Sastre F, Lasunción MA, Ordóñez-Llanos J.
Atherosclerosis. 1997 Jul 25;132(2):207-13.
Biochemical markers of vasospastic coronary artery disease.
Yamaguchi H, Homma Y, Handa S.
Nutr Metab Cardiovasc Dis. 2003 Dec;13(6):365-71.
[The influence of age and the beginning of menopause on the lipid status, LDL oxidation, and CRP in healthy women].
Caparević Z, Kostić N.
Srp Arh Celok Lek. 2007 May-Jun;135(5-6):280-5. Serbian.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on